Latest Research in Immune cells in cancer
35 research papers · 0.1 average citations · 2026 median publication year
Top Research Topics in Immune cells in cancer
- Immune cells in cancer — 5 papers
- Chromatin Remodeling and Cancer — 2 papers
- Cancer Treatment and Pharmacology — 2 papers
- Proteoglycans and glycosaminoglycans research — 1 papers
- Autophagy in Disease and Therapy — 1 papers
- DNA Repair Mechanisms — 1 papers
- Cancer, Stress, Anesthesia, and Immune Response — 1 papers
- Phosphodiesterase function and regulation — 1 papers
- Hippo pathway signaling and YAP/TAZ — 1 papers
- Mathematical Biology Tumor Growth — 1 papers
Highest-Cited Papers
- AMPK γ-Subunit Isoform Switching Governs Temozolomide Resistance and Survival in Glioblastoma (2 citations)
- A non-canonical EZH2/TRIM28 epigenetic axis drives heparan sulfate remodeling and melanoma metastasis
- Autophagy inhibition sensitizes radiotherapy responses in high-grade mutant IDH1 glioma
- SPHINX31 acts as a SRPK1 inhibitor targeting the ATR / DNA ‐ PKcs / CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer
- Benzamil-induced cytotoxicity in non-small cell lung cancer is associated with mitochondrial damage, mitochondrial elongation, and altered XIAP signaling
- Multiscale Transcriptomic Reversal and Structural Docking Identify Repurposing Candidates for Idiopathic Pulmonary Fibrosis
- Intercellular interaction licenses TNFα/IFNγ-induced cancer cell apoptosis through the NF2–YAP–TRAIL pathway
- A Mechanical Confinement Model for the Origin of Oncogenic Transformation: Decoded through the Logikron Deterministic Causal Framework
- Integrating single-cell and spatial multi-omics for precision oncology: from tumor ecosystems to clinical decision-making
- TCM herb pairs regulate breast cancer TME heterogeneous mechanisms in immune, vascular, and stromal compartments
- Acrolein- thioredoxin 1- p38 signaling drives neutrophil-mediated immunosuppression and glioblastoma progression
- Testing for Mechanically Imprinted Drug Resistance in Pancreatic Ductal Adenocarcinoma
- Testing for Mechanically Imprinted Drug Resistance in Pancreatic Ductal Adenocarcinoma
- The FAP × CD3 bispecific antibody OMTX305 induces T cell–mediated antitumor effects in patient-derived ex vivo models of solid tumors
- In vivo CRISPR screens identify dual functions of DNMT3A in mediating tumor immune evasion
- Connexin-mediated regulation of nuclear activity in cancer: Direct and indirect mechanisms
- The Osteosarcoma Tumor Microenvironment: From Cellular Interactions to Advanced Preclinical Models
- Transketolase promotes RNF20 ‐dependent H2BK120 ubiquitination and DNA repair through a non‐enzymatic adaptor function
- The role of RUNX3 in cancer chemoresistance: regulation and therapeutic opportunities
- CAF-mediated immune exclusion in osteosarcoma: mechanisms, translational vulnerabilities, and therapeutic strategies